APP and Alzheimer disease: Another mouse model is an amyloid gene knock-in approach, with the App NL-G-F mouse model used to assist with modelling pre-clinical AD without the potential confounding factor of the prion promoter which leads to over-expression of the amyloid precursor protein (APP).